European Notebook: Trademarks, Trade Secrets And Task Forces
Executive Summary
New European legislation and rules on trademarks and trade secrets, the transatlantic transfer of data, and anticounterfeiting measures advanced during February, while streamlining generics approvals were featured during the EU-US TTIP negotiations; the UK referendum on whether to exit the EU set for mid-June.
You may also be interested in...
French Industry Head Lauds New Drug Pricing Deal
Agreement includes reference price floor for products of higher therapeutic value; trade group says deal reflects "new pragmatism by regulators, with more predictability of pricing and more use of real-world data.
European Notebook: Clinical Trial Fatality; Affordable Medicines Debate; Physician Payment Disclosure
One death and five healthy volunteers hospitalized in a Phase I study in France; EU Council looks set to debate patient access to medicines; and the two Mercks set to continue litigation in Europe and the US over use of the Merck word, straining their 60-year-old agreement. Generics/biosimilar trade group adopts physician payment disclosure policy.
The Brexit Effect: What Would It Mean For Europe's Future Patent System?
UK referendum on whether to remain in EU will take place around the time that the Unified Patent Court is expected to launch.